Improving the knowledge, skills, and strategies that support clinical performance and patient outcomes through the provision of live and on-demand CE
New York, NY
Joined June 2009
- Tweets22.3K
- Following4.9K
- Followers5.4K
- Likes9.6K
PeerView retweeted
Join us Tuesday, 11/10 at 7:00 PM EST for a live virtual #SystemicMastocytosis workshop with Drs. Hussein A. Abbas, MD, PhD (@HusseinAbbasLab) and Cem Akin, MD, PhD, FAAAAI, featuring a live chat with experts: bit.ly/SM2026-T
In collaboration with @PeerView #Allergy
PeerView retweeted
🔥 Got questions on #Asthma, #CRSwNP & #COPD? Join the debate!
💬 Challenge Drs. @DrMonicaKraft, @FrankS1956 & Andrew White! Submit questions & join @PeerView’s live Q&A at #CHEST2026.
📅 Oct 18 | 12 PM MST
👉 Register now: bit.ly/26Airway-T
#MedEd
PeerView retweeted
🫁 Can targeted biologics change #COPD care?
Join @PeerView + experts @FrankS1956, @francypolverino & @VTejwaniMD at #CHEST2026 to discuss treatable traits & personalized care. Bring your questions! 💬
📅 Oct 19 | 6 AM MST
👉 bit.ly/26COPD-T
#MedEd
PeerView retweeted
I'm looking forward to joining Eric van Custem, MD, PHd, and Stephanie PL Saw, MBBS, MMed, MRCP, PhD, for a @PVI, PeerView Institute for Medical Education live in-person symposium at #ESMO26 on leveraging HER2-targeted ADCs in solid tumours.
We'll discuss best practices for HER2 biomarker testing across malignancies, the latest practice-changing data, and how to identify the right patients and integrate these therapies into individualised treatment plans.
Join us Monday, 26 October, at 18:30 CET in Madrid. Register here: bit.ly/MadridADC26-L
PeerView retweeted
🚨 ATTR-CA care is evolving. Are you ready?
Join @PeerView + @joshmitchellmd & @jvaishnavmd at #HFSA2026 for an #ATTRCA symposium on 10.09!
🧠 Test clinical thinking
💬 Apply the latest data
👥 Tackle real-world cases
⚡ Put evidence into practice
🔗 bit.ly/ATTR-26-T
PeerView retweeted
🎯 How would YOU approach the next oHCM case?
Join @PeerView + @DesaiMilindY & @tikuowens at #HFSA2026 to test your clinical thinking, tackle cases & put the latest CMI evidence to work! Don't miss it‼️
📅 10.11 | 7:15 AM MST
🔗 bit.ly/HCM-26-T
PeerView retweeted
🚨 ATTR-CA care is evolving!
Join @PeerView at #HFSA to explore new data, tackle patient cases, and discuss targeted therapies and health equity.
🎤 Drs. Joshua Mitchell (@joshmitchellmd) & Joban Vaishnav (@jvaishnavmd)
📅 Oct 9 | 7:30 PM MST
🔗 bit.ly/ATTR-26-T
PeerView retweeted
🚨 What does the latest CMI evidence mean for oHCM care?
Join @PeerView, Drs. @DesaiMilindY & @tikuowens at #HFSA2026 for interactive #oHCM #MedEd!
📅 Oct 11 | 7:15 AM MST
📍 Phoenix + webcast
💬 Cases. Questions. Practice-changing insights.
🔗 bit.ly/HCM-26-T
PeerView retweeted
🔥 ATTR-CA HOT TOPICS. YOUR QUESTIONS.
Join @PeerView LIVE Sunday, 11/8 at 5:30 PM CST at #AHA #ScientificSessions26‼️
🎤 Ask questions
💬 Join the discussion
🔥 Challenge the experts, Drs. Ahmad Masri (@MasriAhmadMD), Margot Davis & Daniel Judge
🔗 bit.ly/26-ATTR-T
PeerView retweeted
How does an expanded treatment arsenal inform sequencing and combination decisions in relapsed/refractory myeloma? Drs. Sagar Lonial (@SagarLonialMD) and Krina Patel (@DrKrinaPatel) break it down at this @PeerView workshop, 10/6 at 7:00 PM EDT: bit.ly/MMVirtual26-T #MultipleMyeloma
PeerView retweeted
🚨 ONE AIRWAY. THREE DISEASES. A NEW ERA.
#Asthma #CRSwNP #COPD 🔥 Ready for what’s next in precision biologics?
Join @PeerView & Drs. @DrMonicaKraft, @FrankS1956 & Andrew White at #CHEST2026 on 10.18.
💬 Bring your questions. Challenge the experts.
🔗 bit.ly/26Airway-T
PeerView retweeted
🚨 COPD CARE IS EVOLVING
Beyond triple therapy: 🔥 precision biologics, treatable traits & type 2 inflammation
Join @PeerView & Drs. @FrankS1956, @francypolverino & @VTejwaniMD at #CHEST2026
💬 Learn. Engage. Bring your questions
📅 Oct 19 | 6 AM MST
🔗 bit.ly/26COPD-T
PeerView retweeted
Remember to join us Tuesday, 9/15 at 7:00 PM EDT for this live virtual workshop on #CSCC with Nikhil I. Khushalani, MD (@DrKhushalani) and Vishal Anil Patel, MD (@VishPatelMD), in collaboration with @PeerView: bit.ly/CSCC26-T
#SSO
PeerView retweeted
🚨 HER2. New targets. New possibilities.
🔥 What’s next for HER2-overexpressing NSCLC?
Join Drs. Planchard (@dplanchard), Horinouchi (@HHorinouchi) & Smit at @PeerView’s #WCLC26 symposium! Not to be missed‼️
📅 9/14 | 13:45 KST
👉 bit.ly/Seoul26HER2-T
#MedEd #HER2 #NSCLC
PeerView retweeted
Next-generation CAR-T, T-cell engagers, and CELMoDs are reshaping #RRMM treatment, don't miss Drs. Lonial (@SagarLonialMD) and Patel (@DrKrinaPatel) at this @PeerView live virtual workshop, Tuesday 10/6 at 7:00 PM EDT: bit.ly/MMVirtual26-T #MedEd
PeerView retweeted
Which multiple myeloma therapies are FDA- and EMA-approved right now, and how do you sequence them
for relapsed/refractory disease? Find out with our expert faculty at this @PeerView live symposium during
#IMS26: bit.ly/Glasgow2026-T #MultipleMyeloma
PeerView retweeted
We hope you join us tonight for this #CSU webcast!
Tomorrow: PeerView Live goes live with Dr. Adam Friedman on #CSU — 9/9 at 7 PM EDT. Bring your toughest questions: bit.ly/CSU-9
Co-hosted with Ohio Society of Dermatology Physician Assistants | Missouri Dermatological Society | Colorado Dermatologic Society | @Florida_Derm
#Dermatology #MedEd
PeerView retweeted
Which patients with #CSCC benefit most from immunotherapy? Find out with Nikhil I. Khushalani, MD (@DrKhushalani) and Vishal Anil Patel, MD (@VishPatelMD) at this @PeerView workshop, 9/15 @ 7:00 PM EDT: bit.ly/CSCC26-T
#SSO #MedEd
PeerView retweeted
At #WCLC26, be sure to join Drs. Tina Cascone, @bensolomon1 , and me at this very timely @PeerView symposium on Sunday 9/13/26, 6pm local time in Seoul to discuss how bispecific antibodies will impact lung cancer!
Register here (in person or virtual):
lrn.peerview.com/150211777_1…
PeerView retweeted
New treatment options and updated guidelines are improving colorectal cancer outcomes. Tanios Bekaii-Saab, MD (@GIcancerdoc) offers guidance on therapeutic sequencing strategies in this #MedEd activity, in collaboration with @PeerView 👉 bit.ly/4iAE6P6
